Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHVF Large Cap
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
Tickers RHHBF RHHBY RHHVF SABS
Tags RHHBF Market News News
From Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
Tickers ADAP GSK RHHBY
Tags GSK Market News RHHBY
From Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
Tickers BMY BOLT RHHBY
Tags Biotech RHHBY BOLT
From Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
Tickers RHHBY
Tags RHHBY Market News Recent Press Releases
From Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Tickers LLY RHHBY
Tags RHHBY Market News Briefs
From Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHVF Eurasia
From Benzinga
Is Roche a Buy Now?
Tickers RHHBY
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Tickers RHHBY SRPT
Tags Health Care News Briefs
From Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
Tickers RHHBF RHHBY RHHVF
Tags RHHBY FDA Biotech
From Benzinga
The Top 7 Growth Stocks in Biotech
Tickers APVO BEAM CMRX DVAX
Tags Stocks to Buy APVO BEAM
From InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Tickers EXEL RHHBF RHHBY RHHVF
Tags General Benzinga Biotech
From Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
Tickers RHHBY SRPT
Tags RHHBY Market News Recent Press Releases
From Motley Fool
3 Best Growth Stocks to Buy In March
Tickers HIMS IWF MELI RHHBY
Tags MELI VUG RHHBY
From Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
Tickers BPMC RHHBY
Tags News General BPMC
From Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
Tickers BPMC RHHBF RHHBY RHHVF
Tags Briefs RHHBF Market News
From Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
Tickers ABBV INFI MEIP MRK
Tags Benzinga General ABBV
From Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
Tickers REGN RHHBF RHHBY RHHVF
Tags Benzinga General RHHBY
From Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
Tickers RHHBF RHHBY RHHVF
Tags Market News RHHBF RHHBY
From Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
Tickers RHHBF RHHBY RHHVF
Tags Benzinga General Biotech
From Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
Tickers RHHBF RHHBY
Tags Briefs RHHBY RHHBF
From Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Tickers RHHBF RHHBY RHHVF
Tags Benzinga General Biotech
From Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
Tickers AERG ATLX CLNV CYDY
Tags LIACF PVCT OTC Markets Group
From Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
Tickers RHHBF RHHBY RHHVF
Tags Large Cap News RHHVF
From Benzinga
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
Tickers BBBY CRM DAL PFE
Tags RHHBY General DAL
From Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
Tickers RHHBF RHHBY RHHVF
Tags General Benzinga Biotech
From Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Tickers GILD RHHBY
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
Tickers BIIB RHHBF RHHBY RHHVF
Tags Biotech FDA RHHBY
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
Tickers LLY RHHBF RHHBY RHHVF
Tags FDA RHHBY Biotech
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
Tickers GILD MRK RCUS RHHBY
Tags NASDAQ:GILD,NYSE:RCUS,OTCMKTS:RHHBY,NYSE:MRK GILD Today's Market
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.